Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 136 AL 150

Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease

Qu BX, Lambracht-Washington D, Fu M, Eagar TN, Stüve O, Rosenberg RN.

Vaccine. 2010 Jul 19;28(32):5280-7. doi: 10.1016/j.vaccine.2010.05.054. Epub 2010 Jun 4.

Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials

McArthur RA, Gray J, Schreiber R.

Curr Opin Investig Drugs. 2010 Jul;11(7):740-60.

Antioxidant approaches for the treatment of Alzheimer's disease

Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G.

Expert Rev Neurother. 2010 Jul;10(7):1201-8. doi: 10.1586/ern.10.74.

[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]

Wouters CJ, Dautzenberg L, Thissen A, Dautzenberg PL.

Tijdschr Gerontol Geriatr. 2010 Jun;41(3):146-50. doi: 10.1007/BF03096196.

Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels

Timmer NM, van Dijk L, van der Zee CE, Kiliaan A, de Waal RM, Verbeek MM.

Neurobiol Dis. 2010 Oct;40(1):340-7. doi: 10.1016/j.nbd.2010.06.008. Epub 2010 Jun 22.

Alzheimer's disease: clinical trials and drug development

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M.

Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8.

Learning from failure

Nat Rev Drug Discov. 2010 Jul;9(7):499. doi: 10.1038/nrd3222.

Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues

Obulesu M, Rao DM.

Int J Neurosci. 2010 Aug;120(8):531-7. doi: 10.3109/00207451003760080.

[Effect of compound Polygonum multiflorum extract on Alzheimer's disease]

Chen L, Huang J, Xue L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jun;35(6):612-5. doi: 10.3969/j.issn.1672-7347.2010.06.012.

[Animal models of Alzheimer's disease for preclinical research.]

Takahashi H.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):6-10. doi: 10.1254/fpj.136.6.

[Pharmacological properties of T-817MA, a novel neurotrophic agent, for treatment of Alzheimer's disease.]

Fukushima T.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):11-4. doi: 10.1254/fpj.136.11.

[Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.]

Shitaka Y, Mitani Y, Nagakura A, Miyake A, Matsuoka N.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):15-20. doi: 10.1254/fpj.136.15.

[Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.]

Araki S.

Nihon Yakurigaku Zasshi. 2010 Jul;136(1):21-5. doi: 10.1254/fpj.136.21.

Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease

Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F.

Curr Med Chem. 2010;17(27):2990-3006. doi: 10.2174/092986710791959729.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias